Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Income from Continuing Operations (2016 - 2025)

Prestige Consumer Healthcare has reported Income from Continuing Operations over the past 16 years, most recently at 46696000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 23.49% year-over-year to 46696000.0; the TTM value through Dec 2025 reached 186501000.0, down 12.82%, while the annual FY2025 figure was 214605000.0, 2.52% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 46696000.0 at Prestige Consumer Healthcare, up from 42211000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 61032000.0 in Q4 2024 and troughed at 240552000.0 in Q1 2023.
  • A 5-year average of 35945300.0 and a median of 50619000.0 in 2021 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: crashed 561.84% in 2023 and later soared 120.56% in 2024.
  • Year by year, Income from Continuing Operations stood at 50215000.0 in 2021, then grew by 3.46% to 51951000.0 in 2022, then rose by 2.11% to 53046000.0 in 2023, then rose by 15.05% to 61032000.0 in 2024, then fell by 23.49% to 46696000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for PBH at 46696000.0 in Q4 2025, 42211000.0 in Q3 2025, and 47466000.0 in Q2 2025.